Immunome (IMNM)
(Delayed Data from NSDQ)
$10.59 USD
+0.07 (0.67%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $10.60 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Immunome, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IMNM 10.59 +0.07(0.67%)
Will IMNM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMNM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IMNM
Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock?
Immunome (IMNM) Upgraded to Buy: Here's What You Should Know
IMNM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High?
Wall Street Analysts Think Immunome (IMNM) Could Surge 188.57%: Read This Before Placing a Bet
All You Need to Know About Immunome (IMNM) Rating Upgrade to Buy
Other News for IMNM
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IMNM Stock News
Bullish Two Hundred Day Moving Average Cross - IMNM
September 19th Options Now Available For Immunome (IMNM)
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | IMNM Stock News
Immunome Elects New Directors at Annual Meeting